Matches in DBpedia 2014 for { <http://dbpedia.org/resource/CJC-1295> ?p ?o. }
Showing items 1 to 28 of
28
with 100 items per page.
- CJC-1295 abstract "CJC-1295 is a tetrasubstituted 30-amino acid peptide hormone, primarily functioning as a growth hormone releasing hormone (GHRH) analog. It was invented by ConjuChem, a Canadian biotechnology company.One of the advantages of CJC-1295 over traditional GHRH or rHGH is its ability to bioconjugate with serum albumin, thus increasing its half-life and therapeutic window. It accomplishes this by using protecting groups around the amino acids of GHRH typically susceptible to enzymatic degradation.".
- CJC-1295 atcPrefix "none".
- CJC-1295 casNumber "863288-34-0".
- CJC-1295 pubchem "56841945".
- CJC-1295 wikiPageID "18609845".
- CJC-1295 wikiPageRevisionID "599551769".
- CJC-1295 atcPrefix "none".
- CJC-1295 c "152".
- CJC-1295 casNumber "863288".
- CJC-1295 h "252".
- CJC-1295 hasPhotoCollection CJC-1295.
- CJC-1295 legalStatus "Investigational".
- CJC-1295 molecularWeight "3367.9".
- CJC-1295 n "44".
- CJC-1295 o "42".
- CJC-1295 pubchem "56841945".
- CJC-1295 routesOfAdministration Subcutaneous_injection.
- CJC-1295 smiles "CC[C@H][C@@H]NC[C@H]NC[C@H]NC[C@@H]NC[C@H]N".
- CJC-1295 subject Category:Growth_hormone_secretagogues.
- CJC-1295 type Drug.
- CJC-1295 type FunctionalSubstance.
- CJC-1295 comment "CJC-1295 is a tetrasubstituted 30-amino acid peptide hormone, primarily functioning as a growth hormone releasing hormone (GHRH) analog. It was invented by ConjuChem, a Canadian biotechnology company.One of the advantages of CJC-1295 over traditional GHRH or rHGH is its ability to bioconjugate with serum albumin, thus increasing its half-life and therapeutic window. It accomplishes this by using protecting groups around the amino acids of GHRH typically susceptible to enzymatic degradation.".
- CJC-1295 label "CJC-1295".
- CJC-1295 sameAs m.04gh2kz.
- CJC-1295 sameAs Q5012018.
- CJC-1295 sameAs Q5012018.
- CJC-1295 wasDerivedFrom CJC-1295?oldid=599551769.
- CJC-1295 isPrimaryTopicOf CJC-1295.